143 related articles for article (PubMed ID: 35567391)
1. T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.
Taeschler P; Adamo S; Deng Y; Cervia C; Zurbuchen Y; Chevrier S; Raeber ME; Hasler S; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Bodenmiller B; Boyman O; Nilsson J
Allergy; 2022 Aug; 77(8):2468-2481. PubMed ID: 35567391
[TBL] [Abstract][Full Text] [Related]
2. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
[TBL] [Abstract][Full Text] [Related]
3. Persistent High Percentage of HLA-DR
Du J; Wei L; Li G; Hua M; Sun Y; Wang D; Han K; Yan Y; Song C; Song R; Zhang H; Han J; Liu J; Kong Y
Front Immunol; 2021; 12():735125. PubMed ID: 34567001
[TBL] [Abstract][Full Text] [Related]
4. Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.
Adamo S; Chevrier S; Cervia C; Zurbuchen Y; Raeber ME; Yang L; Sivapatham S; Jacobs A; Baechli E; Rudiger A; Stüssi-Helbling M; Huber LC; Schaer DJ; Bodenmiller B; Boyman O; Nilsson J
Allergy; 2021 Sep; 76(9):2866-2881. PubMed ID: 33884644
[TBL] [Abstract][Full Text] [Related]
5. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
6. CD4
Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
[No Abstract] [Full Text] [Related]
7. The unreversible reduced but persistent activated NK and CD8
Qin L; Duan X; Dong JZ; Chang Y; Han Y; Li Y; Jiang W; Fan H; Hou X; Cao W; Zhu H; Li T
Emerg Microbes Infect; 2023 Dec; 12(1):2208679. PubMed ID: 37102227
[TBL] [Abstract][Full Text] [Related]
8. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
Front Immunol; 2020; 11():596553. PubMed ID: 33324414
[TBL] [Abstract][Full Text] [Related]
9. The clinical and immunological characteristics of COVID-19 patients with delayed SARS-CoV-2 virus clearance.
Wang J; Li D; Tang B; Sun X; Shi W; Li H; Zhang Z; Wu Y; Zhang Y; Qiao Q
Immun Inflamm Dis; 2023 Sep; 11(9):e999. PubMed ID: 37773701
[TBL] [Abstract][Full Text] [Related]
10. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.
Liu Y; Pan Y; Hu Z; Wu M; Wang C; Feng Z; Mao C; Tan Y; Liu Y; Chen L; Li M; Wang G; Yuan Z; Diao B; Wu Y; Chen Y
Clin Infect Dis; 2020 Nov; 71(16):2150-2157. PubMed ID: 32442287
[TBL] [Abstract][Full Text] [Related]
11. Synergism of CD28 Immune Molecule in Late Immunosuppressive Phase of COVID-19: Effectiveness in Vaccinated Individuals.
Alharbi KS; Singh Y; Prasad Agrawal G; Altowayan WM; Almalki WH; Sharma A; Singh SK; Jha NK; Chellappan DK; Dua K; Gupta G
Altern Ther Health Med; 2023 Apr; 29(3):67-73. PubMed ID: 35212647
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Levels of Peripheral CD3
Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
[TBL] [Abstract][Full Text] [Related]
13. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
d'Ettorre G; Recchia G; Ridolfi M; Siccardi G; Pinacchio C; Innocenti GP; Santinelli L; Frasca F; Bitossi C; Ceccarelli G; Borrazzo C; Antonelli G; Scagnolari C; Mastroianni CM
Medicine (Baltimore); 2020 Sep; 99(36):e21803. PubMed ID: 32899009
[TBL] [Abstract][Full Text] [Related]
14. Persistent CD8
LaVergne SM; Dutt TS; McFann K; Baxter BA; Webb TL; Berry K; Tipton M; Stromberg S; Sullivan BM; Dunn J; Henao-Tamayo M; Ryan EP
Front Immunol; 2023; 14():1303971. PubMed ID: 38327763
[TBL] [Abstract][Full Text] [Related]
15. T cell maturation is significantly affected by SARS-CoV-2 infection.
Walter LO; Cardoso CC; Santos-Pirath ÍM; Costa HZ; Gartner R; Werle I; Mohr ETB; da Rosa JS; Lubschinski TL; Felisberto M; Kretzer IF; Masukawa II; Vanny PA; Luiz MC; de Moraes ACR; Dalmarco EM; Santos-Silva MC
Immunology; 2023 Jul; 169(3):358-368. PubMed ID: 36855300
[TBL] [Abstract][Full Text] [Related]
16. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
Front Immunol; 2021; 12():684014. PubMed ID: 34194438
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 Patients.
Mo Y; To KK; Zhou R; Liu L; Cao T; Huang H; Du Z; Lim CYH; Yim LY; Luk TY; Chan JM; Chik TS; Lau DP; Tsang OT; Tam AR; Hung IF; Yuen KY; Chen Z
Front Immunol; 2021; 12():799896. PubMed ID: 35095881
[TBL] [Abstract][Full Text] [Related]
18. Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months.
Santopaolo M; Gregorova M; Hamilton F; Arnold D; Long A; Lacey A; Oliver E; Halliday A; Baum H; Hamilton K; Milligan R; Pearce O; Knezevic L; Morales Aza B; Milne A; Milodowski E; Jones E; Lazarus R; Goenka A; Finn A; Maskell N; Davidson AD; Gillespie K; Wooldridge L; Rivino L
Elife; 2023 Jun; 12():. PubMed ID: 37310006
[TBL] [Abstract][Full Text] [Related]
19. Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.
Clavarino G; Leroy C; Epaulard O; Raskovalova T; Vilotitch A; Pernollet M; Dumestre-Pérard C; Defendi F; Le Maréchal M; Le Gouellec A; Audoin P; Bosson JL; Poignard P; Roustit M; Jacob MC; Cesbron JY
Front Immunol; 2022; 13():889813. PubMed ID: 35911748
[TBL] [Abstract][Full Text] [Related]
20. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
